Introduction
Managing diabetes often requires consistent blood glucose control and, for some patients, daily basal insulin therapy. Semglee is a long-acting insulin that provides once-daily basal insulin to help maintain blood glucose levels in adults and children with diabetes mellitus.
Semglee is available as a U-100 solution in a multiple-dose vial and prefilled pen. For eligible patients who face challenges accessing their medication, Prescription Hope may help navigate prescription assistance and treatment costs.
What Is the Semglee Patient Assistance Program?
Pharmaceutical manufacturers recognize that not everyone can afford name-brand medication. Many patients require low-cost brand-name medication access.
To help, pharmaceutical manufacturers have developed patient assistance programs to help with , such as the Semglee patient assistance program. With these patient assistance programs, qualified patients get access to the name-brand medication they need at a lower cost than market rate.
Unfortunately, patient assistance programs like the Semglee prescription assistance often require extensive research, coordination with the pharmaceutical manufacturer and healthcare providers, and documentation. This can lead to feelings of stress and overwhelm as the patient tries to obtain the medications they need.
Fortunately, Prescription Hope can help.
How Expert Advocates Help Make Semglee More Affordable
Personalized Medication Assistance
Prescription Hope’s Semglee medication support services provide qualified patients access to the name-brand medications they need at a lower cost than retail.
Our team of medication access advocates supports you through the difficulties of applying for diabetes patient support. Our team helps qualified patients with administrative tasks related to applying to a patient assistance program, such as forms, documents and signatures, communication with healthcare providers, coordinating with manufacturers, and more.
Ongoing Patient Support
Prescription Hope’s access advocates support qualified patients even after acceptance into a patient assistance program. Our continuing medication assistance includes refill scheduling, document updates, yearly renewals, program monitoring, and more.
Semglee Patient Assistance Eligibility
Patients looking to apply for Semglee medication access need to understand the requirements for Semglee prescription assistance eligibility. Since patient assistance programs set criteria in specific areas, patients should know ahead of time whether they will qualify. Some of these categories include:
Income: Each patient assistance program sets its own income threshold requirements patients must meet.
Insurance: Each program also sets its own acceptable insurance coverage status.
Prescription: All patients must have a valid prescription for their intended brand-name medication.
U.S. Residency: Patients must be legal residents of the United States.
Simple Enrollment With Expert Support
Do you want help with your Semglee assistance enrollment? Are you looking for Semglee application support? Applying to Prescription Hope’s medication access service takes 6 simple steps:
- Submit Information: Take a few minutes to fill out our online enrollment form.
- Advocate Contact: After we review your enrollment form, a patient advocate will contact you in 1-2 business days.
- Document Collection: Our team will collect all necessary documents from you and your healthcare provider following prequalification.
- Provider Coordination: Our team will also gather any signatures needed from your healthcare provider.
- Program Submission: Once everything is in order, we will submit your application to the prescription assistance program and continue coordinating with your healthcare provider and the pharmaceutical manufacturer.
- Medication Delivery: Qualified patients should receive their name-brand medication 1-2 weeks after their application is cleared. Medications are shipped directly from the manufacturer to the patient’s door or doctor’s office.
Understanding Semglee
How Semglee Works
Semglee contains insulin glargine-yfgn, a long-acting human insulin analog. Insulin glargine lowers blood glucose by increasing glucose uptake into peripheral tissues, particularly skeletal muscle and fat, while reducing glucose production by the liver.
It also inhibits lipolysis and proteolysis and promotes protein synthesis. As a long-acting insulin, insulin glargine provides a relatively constant glucose-lowering effect over approximately 24 hours without a pronounced peak.
What Conditions Does Semglee Treat?
Semglee is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. In type 1 diabetes, Semglee provides basal insulin and must be used with short-acting insulin.
This medication is not recommended for the treatment of diabetic ketoacidosis.
Benefits of Treatment
Semglee provides once-daily basal insulin to help maintain blood glucose control. Clinical studies of insulin glargine demonstrated similar reductions in HbA1c compared with NPH insulin in the studied populations. This medication is also an FDA-designated interchangeable biosimilar to Lantus (insulin glargine).
Important Safety Information and Side Effects
Hypoglycemia
Severe hypoglycemia is the most common adverse reaction associated with insulin and can be life-threatening. Blood glucose should be monitored as appropriate, particularly when changing insulin regimens.
Changes in Insulin Regimen
Changing insulin strength, manufacturer, type, injection site, or administration method can cause hyperglycemia or hypoglycemia. Appropriate glucose monitoring is important when making these changes.
Medication Errors and Insulin Identification
Insulin products can be accidentally confused with one another. Patients should check the insulin label before every injection.
Semglee prefilled pens, syringes, or needles should never be shared between patients, even if the needle is changed.
Hypersensitivity
Severe, potentially life-threatening allergic reactions, including anaphylaxis, can occur with insulin products.
Hypokalemia
Insulin can shift potassium into cells and cause potentially serious decreases in blood potassium levels.
Fluid Retention and Heart Failure
Thiazolidinediones used with insulin can cause fluid retention and may worsen heart failure.
Injection-Site Complications
Repeated injections into areas of lipodystrophy or localized cutaneous amyloidosis can affect glucose control. Injection sites should be rotated within the same region.
Drug Interactions
Several medications can increase the risk of hypoglycemia, including other antidiabetic agents, ACE inhibitors, ARBs, fibrates, fluoxetine, MAO inhibitors, pramlintide, salicylates, sulfonamide antibiotics, GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT-2 inhibitors.
Corticosteroids, diuretics, estrogens, oral contraceptives, atypical antipsychotics, sympathomimetics, thyroid hormones, and several other medications may reduce insulin’s glucose-lowering effect.
Beta-blockers, clonidine, guanethidine, and reserpine may blunt some symptoms of hypoglycemia. Pentamidine may cause hypoglycemia, which may sometimes be followed by hyperglycemia.
Pregnancy and Breastfeeding
Available published studies have not identified a clear association between insulin glargine products and adverse developmental outcomes. Poorly controlled diabetes itself carries significant maternal and fetal risks.
There are limited data regarding insulin glargine in human milk. Endogenous insulin is present in human milk, and the benefits of breastfeeding should be considered alongside the mother’s clinical need for Semglee and potential effects on the breastfed child.
Common Side Effects
Common adverse reactions associated with insulin glargine products include hypoglycemia, allergic reactions, injection-site reactions, lipodystrophy, itching, rash, edema, and weight gain.
Access to Multiple Medications
Some patients looking for specialty medication access are also looking for multiple medication assistance programs. Prescription Hope offers medication affordability support for hundreds of name-brand medications and their associated prescription assistance programs.
Assistance for multiple medications is available through Prescription Hope medication assistance at the low rate of $70.00 per month, per medication.
Why Choose Prescription Hope for Semglee Assistance?
Patient-Focused Medication Support
Since 2006, Prescription Hope has helped qualified patients get access to the name-brand medication they need at a low cost. Our team of patient advocates is equipped to advocate for you and give you the support you need.
Simplified Access to Specialty Therapies
All of Prescription Hope’s services are available to you at a cost-effective rate of $70.00 per month, per medication. There are no add-ons, hidden charges, or medication costs. If our team can’t help you find a way to save, you pay us nothing.
Ongoing Prescription Assistance
Prescription Hope doesn’t just offer diabetes medication assistance. We also provide ongoing personalized medication assistance. Some of the administrative tasks we continue to help with include refill scheduling, yearly renewals, document updates, program monitoring, and more.
Network Access
Our network spans the America, offering qualified patients access to hundreds of name-brand medications and their associated patient assistance programs.
If you need diabetes medication assistance or are looking for Semglee prescription support, reach out to Prescription Hope to get started today!